Hubei Guangji Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 476.33 million compared to CNY 512.93 million a year ago. Revenue was CNY 476.33 million compared to CNY 512.93 million a year ago. Net income was CNY 74.18 million compared to CNY 47.82 million a year ago. Basic earnings per share from continuing operations was CNY 0.2156 compared to CNY 0.1443 a year ago. Diluted earnings per share from continuing operations was CNY 0.2156 compared to CNY 0.1443 a year ago.